Discover ioCells

Programmed identity
in every cell

Human iPSC-derived cells powered by opti-ox, consistency and scalability are built-in.

Mature, functional human
iPSC-derived cells within days,
powered by opti-ox

The future of human health will be defined by technologies that accelerate the world's access to more effective medicines.

Human cells are a cornerstone of fundamental disease research, drug discovery, and clinical translation. Yet, despite decades of research into iPSCs, emerging cures for some of the world’s most pervasive diseases have been bottlenecked by a lack of access to standardised, easy to use and readily accessible human cells.

We built ioCells to solve this challenge.

Developed on our platform, and powered by opti-ox technology, ioCells are human cells deterministically programmed from iPSCs consistently, at scale. With ioCells, scientists no longer need to battle with variance, unreliability, physiological irrelevance and long experimental timelines. Instead, scientists can finally focus on the next great advances in human health.

ioCells are for research use only.

Browse ioCells portfolio

ioSkeletal Myocytes_for partners module

ioWild Type Cells

ioWild Type Cells are defined, easy-to-use, functional iPSC-derived human cells from a healthy donor background that are ready for fundamental research and drug discovery experimentation within days.

Discover ioCells portfolio ICC ioDisease model cells

ioDisease Model Cells

ioDisease Model Cells are ioWild Type Cells engineered to contain disease-relevant mutations. ioDisease Model Cells and ioWild Type Cells form an isogenic pair allowing scientists to make true comparisons.

Discover ioCells portfolio ICC ioCRISPR Ready Cells (1)

CRISPR-Ready ioCells

CRISPR-Ready ioCells are human iPSC-derived cells constitutively expressing Cas9 nuclease for rapid gene knockout generation. 

bitbio-homepage_banner-custom_cells-desktop-1

Custom Cell Development

We provide our partners with the ability to develop and access any human cell type at scale, removing the experimental burden of cell models that are not translatable, scalable or an accurate representation of disease

Benchtop benefits

consistent_0

Consistent

Our platform ensures consistency between every batch of cells, overcoming the challenge of data reproducibility.

cost_0

Cost-effective

ioCells generate quality data at industry leading seeding densities. You can do more with every vial as every well saves you money.

defined_0

Defined

Every ioCell has its identity characterised by ICC, RT-qPCR and RNA-Seq at minimum.

easy_0

Easy-to-use

ioCells are delivered cryopreserved and require a simple protocol using an open-source medium to get started.

quick_0

Quick

Deterministically programmed cells mature rapidly, meaning cells are ready for experimentation and data gathering within days post-revival.

scalable_0

Scalable

With opti-ox technology we can make billions of consistently programmed cells, surpassing the demands of industrial workflows.

What Scientists Say About ioCells

An image of Dr Marijn Vlaming

Dr Marijn Vlaming

Head of Biology - Beerse & Leiden | Charles River

"Using more relevant cell models such as ioCells from bit.bio helps us to test safety and toxicity in vitro, in parallel with efficacy, and as such we will be able to identify the safe or unsafe drug candidates very early in the drug discovery process"

An image of Dr Mariangela Iovino

Dr Mariangela Iovino

Senior Group Leader | Biology Discovery | Charles River

“These cells were really easy-to-use and ready to be plated in the assay format"

An image of Rodney A. Bowling Jr, PhD

Rodney A. Bowling Jr, PhD

Co-Founder & Chief Scientific Officer | Everlum Bio

"I found the customer service at bit.bio to be a premium, I found it to be wonderful”

Our deterministic cell programming technology

 

opti-ox-cell_7fps_v03_00033

Every ioCell is powered by opti-ox.


Using opti-ox, populations of stem cells are precisely and consistently programmed into a chosen cell identity. Each vial of ioCells contains a defined and highly characterised population of iPSC-derived human cells that are ready for quality data production in a matter of days. Their high lot-to-lot consistency provides a reliable cell model that enables scientists to conduct repeatable and scalable experiments in drug discovery and disease research. 

Product resources

(LinkedValues: [{hs_name=High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery, hs_id=161961134487, hs_path=charles-river-poster-high-content-analysis-of-cellular-models, button_label=View poster, button_link=https://bit.bio/hubfs/BitBio_April2021/pdf%20link/2020_Lachize-et-al_High-Content-Analysis-of-2D-and-3D-Cellular-Models_Charles-River.pdf, type={value=Poster, label=Poster}, thumbnail={alt_text=, width=1700, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioGlutamatergic%20Neurons/bitbio-ioGlutamatergic-Neurons.jpg, height=1300}, year={value=2020, label=2020}, summary=<p>Lachize, et al</p> <p>Courtesy of Charles River Laboratories</p> <p>2020</p>, date_published=1706313600000, sort_date=1602806400000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=null, listing_button_label=View}, {hs_name=Development and characterisation of a robust in vitro disease model to study tauopathies, hs_id=161961134488, hs_path=ftd-mapt-phenotype-poster-charles-river-mar23, button_label=View poster, button_link=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Resources/SFN2022-Development-and-characterization-of-a-robust-in-vitro-disease-model-to-study-tauopathies.pdf, type={value=Poster, label=Poster}, thumbnail={alt_text=, width=1000, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/MAPT%20P301S/MAPT%20P301SP301S%20final%20homepage%20image.jpg, height=1400}, year={value=2022, label=2022}, summary=<p>Ritsma, et al</p> <p>Charles River Laboratories &amp; bit.bio</p> <p>2022</p>, date_published=1708646400000, sort_date=1678924800000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGlutamatergic Neurons MAPT P301S/WT, label=ioGlutamatergic Neurons MAPT P301S/WT}, {value=ioGlutamatergic Neurons MAPT P301S/P301S, label=ioGlutamatergic Neurons MAPT P301S/P301S}, {value=ioGlutamatergic Neurons MAPT N279K/WT, label=ioGlutamatergic Neurons MAPT N279K/WT}], media_contact=null, listing_button_label=View}, {hs_name=Rapid and consistent generation of functional microglia from reprogrammed hiPSCs to study neurodegeneration and neuroinflammation, hs_id=161961134491, hs_path=poster-rapid_and_consistent_generation_of_functional_ipsc_derived_microglia, button_label=View poster, button_link=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioMicroglia/bitbio-ioMicroglia_poster-V7-press_SfN%202022.pdf, type={value=Poster, label=Poster}, thumbnail={alt_text=, width=1504, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Emails/Header%20images/Header%20Images%20-%20ICC%20only/Microglia%20blog%20email%20header%20format.png, height=850}, year={value=2022, label=2022}, summary=<p>Raman, et al</p> <p>bit.bio</p> <p>2022</p>, date_published=1709251200000, sort_date=1669680000000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioMicroglia, label=ioMicroglia}], media_contact=null, listing_button_label=View}, {hs_name=Modelling neurodegeneration: Human isogenic system to study FTD & ALS, hs_id=161961134492, hs_path=ftd-als-mapt-tdp-43-disease-models-adpd-2023-poster-mar23, button_label=View poster, button_link=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Resources/bitbio_ioGlutamatergic%20Neurons%20MAPT%20TDP-43%20Disease%20Model%20poster_v2.pdf, type={value=Poster, label=Poster}, thumbnail={alt_text=, width=1966, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/MAPT%20N279K/N279K%20MAP2%20brightfield%20compressed%20rotated.png, height=1966}, year={value=2023, label=2023}, summary=<p>Oosterveen, et al</p> <p>bit.bio &amp; Charles River Laboratories</p> <p>2023</p>, date_published=1709424000000, sort_date=1687478400000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGlutamatergic Neurons HTT 50CAG/WT, label=ioGlutamatergic Neurons HTT 50CAG/WT}, {value=ioGlutamatergic Neurons TDP-43 M337V Het, label=ioGlutamatergic Neurons TDP-43 M337V Het}, {value=ioGlutamatergic Neurons TDP-43 M337V Hom, label=ioGlutamatergic Neurons TDP-43 M337V Hom}, {value=ioGlutamatergic Neurons MAPT P301S/WT, label=ioGlutamatergic Neurons MAPT P301S/WT}, {value=ioGlutamatergic Neurons MAPT P301S/P301S, label=ioGlutamatergic Neurons MAPT P301S/P301S}, {value=ioGlutamatergic Neurons MAPT N279K/WT, label=ioGlutamatergic Neurons MAPT N279K/WT}], media_contact=null, listing_button_label=View}, {hs_name=Generation and characterisation of a panel of human iPSC-derived neurons and microglia carrying early and late onset relevant mutations for Alzheimer’s disease, hs_id=161961134495, hs_path=slas2024-ad-poster, button_label=null, button_link=null, type={value=Poster, label=Poster}, thumbnail={alt_text=, width=1800, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioMicroglia/Microglia%20hero%202%20resize%20brighten%20v2%20compress.png, height=1800}, year={value=2024, label=2024}, summary=Smith, et al.&nbsp;<br>bit.bio<br>2024, date_published=1711065600000, sort_date=1708300800000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGABAergic Neurons, label=ioGABAergic Neurons}, {value=ioMicroglia, label=ioMicroglia}], media_contact=Smith et al.&nbsp;<br>bit.bio<br>2024, listing_button_label=Download}, {hs_name=Lipid-Bilayer-Supported 3D Printing of Human Cerebral Cortex Cells Reveals Developmental Interactions , hs_id=161968263464, hs_path=lipid-bilayer-supported-3d-printing-of-human-cerebral-cortex-cells-reveals-developmental-interactions, button_label=Read more, button_link=https://onlinelibrary.wiley.com/doi/10.1002/adma.202002183, type={value=Publication, label=Publication}, thumbnail={alt_text=, width=666, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/BitBio2022/Resources/Resource-thumbs/resized/New%20Project%20(13).jpeg, height=428}, year={value=2020, label=2020}, summary=<p>Zhou L, et al&nbsp;</p> <p><em>Advanced Science News</em></p> <p>2020</p> <p><a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank">Using ioGlutamatergic Neurons</a></p>, date_published=1592092800000, sort_date=1598659200000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p>Zhou L, et al</p> <p><em>Advanced Science News</em></p> <p>2020</p> <p>Using <a href="https://www.bit.bio/glutamatergic-neurons" rel="noopener">ioGlutamatergic Neurons</a></p>, listing_button_label=Read more}, {hs_name=Reprogramming the stem cell for a new generation of cures, hs_id=161968263465, hs_path=reprogramming-the-stem-cell-for-a-new-generation-of-cures, button_label=Read more, button_link=https://www.ddw-online.com/reprogramming-the-stem-cell-for-a-new-generation-of-cures-1459-202004/, type={value=Publication, label=Publication}, thumbnail={alt_text=, width=2092, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/bit.bio%20ioGlutamatergic%20Neurons%202022.jpg, height=1584}, year={value=2020, label=2020}, summary=<p>Davenport A, Frolov T &amp; Kotter M</p> <p><em>Drug Discovery World</em></p> <p>2020</p> <p>&nbsp;</p> <p>&nbsp;</p>, date_published=1585872000000, sort_date=1597968000000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioSkeletal Myocytes, label=ioSkeletal Myocytes}, {value=ioGABAergic Neurons, label=ioGABAergic Neurons}, {value=ioMicroglia, label=ioMicroglia}, {value=ioSensory Neurons, label=ioSensory Neurons}, {value=ioMotor Neurons, label=ioMotor Neurons}, {value=ioAstrocytes, label=ioAstrocytes}], media_contact=<p><span>Davenport A, Frolov T &amp; Kotter M.</span></p> <p><em>Drug Discovery World</em></p> <p>2020</p> <p>&nbsp;</p> <p>&nbsp;</p>, listing_button_label=Read more}, {hs_name=Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes , hs_id=161968263466, hs_path=inducible-and-deterministic-forward-programming-of-human-pluripotent-stem-cells, button_label=Read more, button_link=https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(17)30083-8, type={value=Publication, label=Publication}, thumbnail={alt_text=, width=759, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/publication-Inducible-and-deterministic-colour.jpg, height=461}, year={value=2017, label=2017}, summary=<p>Pawlowski M et al<br><em>Stem Cell Reports</em></p> <p>2017</p>, date_published=1491868800000, sort_date=1499385600000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p><span>Pawlowski M, et al</span></p> <p><em>Stem Cell Reports</em></p> <p>2017</p> <p>&nbsp;</p>, listing_button_label=Read more}, {hs_name=Compounds co-targeting kinases in axon regulatory pathways promote regeneration and behavioral recovery after spinal cord injury in mice, hs_id=161968263467, hs_path=compounds-co-targeting-kinases-in-axon-regulatory-pathways-promote-regeneration-and-behavioral-recovery-after-spinal-cord-injury-in-mice, button_label=Read more, button_link=https://pubmed.ncbi.nlm.nih.gov/35588791/, type={value=Publication, label=Publication}, thumbnail={alt_text=, width=1871, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Resources/Publications/bit.bio_single%20image_ioGlutamatergic%20Neurons%20Mah%20et%20al%202022.jpg, height=1417}, year={value=2022, label=2022}, summary=<p>Mah, et al</p> <p><em>Experimental Neurology</em></p> <p>2022</p> <p>Using <a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank">ioGlutamatergic Neurons</a></p>, date_published=1652659200000, sort_date=1667260800000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p>Mah, et al</p> <p><em>Experimental Neurology</em></p> <p>2022</p> <p>Using <a href="https://www.bit.bio/glutamatergic-neurons" rel="noopener">ioGlutamatergic Neurons</a></p>, listing_button_label=Read more}, {hs_name=Glutamatergic Neurons and Brain Cyst Formation , hs_id=161968263468, hs_path=glutamatergic-neurons-and-brain-cyst-formation, button_label=Read more, button_link=https://www.frontiersin.org/articles/10.3389/fcimb.2021.788303/full, type={value=Publication, label=Publication}, thumbnail={alt_text=, width=2092, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/bit.bio%20ioGlutamatergic%20Neurons%202022.jpg, height=1584}, year={value=2022, label=2022}, summary=<p>Bando, et al</p> <p><em>Frontiers in Cellular and Infection Microbiology</em></p> <p>2022</p> <p>Using<a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank"> ioGlutamatergic Neurons</a></p> <p>&nbsp;</p> <p>&nbsp;</p>, date_published=1641859200000, sort_date=1667347200000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p>Bando, et al<br><br><em>Frontiers in Cellular and Infection Microbiology</em></p> <p>2022</p> <p>Using <a href="https://www.bit.bio/glutamatergic-neurons" rel="noopener">ioGlutamatergic Neurons</a></p>, listing_button_label=Read more}, {hs_name=Interferon-γ exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression , hs_id=161968263469, hs_path=interferon-γ-exposure-of-human-ipsc-derived-neurons-alters-major-histocompatibility-complex-i-and-synapsin-protein-expression, button_label=Read more, button_link=https://www.frontiersin.org/articles/10.3389/fpsyt.2022.836217/full, type={value=Publication, label=Publication}, thumbnail={alt_text=, width=3742, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Resources/Publications/bit.bio%20ioGlutamatergic%20Neurons%20pavlinek%20et%20al%202022.jpg, height=2836}, year={value=2022, label=2022}, summary=<p>Pavinlek, et al</p> <p><em>Frontiers in Psychiatry</em></p> <p>2022</p> <p>Using <a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank">ioGlutamatergic Neurons</a></p> <p>&nbsp;</p> <p>&nbsp;</p>, date_published=1663113600000, sort_date=1667433600000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p>Pavinlek, et al<br><br><em>Frontiers in Psychiatry</em></p> <p>2022</p> <p>Using <a href="https://www.bit.bio/glutamatergic-neurons" rel="noopener">ioGlutamatergic Neurons</a></p>, listing_button_label=Read more}, {hs_name=Rewiring of the promoter-enhancer interactome and regulatory landscape in glioblastoma orchestrates gene expression underlying neurogliomal synaptic communication, hs_id=178039124124, hs_path=rewiring-of-the-promoter-nature-article, button_label=Read more, button_link=https://www.nature.com/articles/s41467-023-41919-x, type={value=Publication, label=Publication}, thumbnail={alt_text=bitbio-ioGlutamatergic-Neurons, width=1700, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioGlutamatergic%20Neurons/bitbio-ioGlutamatergic-Neurons.jpg, height=1300}, year={value=2023, label=2023}, summary=<p>Chakraborty et al<br><em>Nature Communications</em><br>2023</p> <p>Featuring&nbsp;<a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank">ioGlutamatergic Neurons</a></p>, date_published=1697155200000, sort_date=1697155200000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p>Chakraborty et al<br><em>Nature Communications</em><br>2023</p> <p>Featuring <a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank">ioGlutamatergic Neurons</a></p>, listing_button_label=Read more}, {hs_name=HNRNPH1 regulates the neuroprotective cold‐shock protein RBM3 expression through poison exon exclusion, hs_id=178039124146, hs_path=hnrnph1-regulates-the-neuroprotective-cold-shock-protein-rbm3-expression-through-poison-exon-exclusion-article, button_label=Read more, button_link=https://www.embopress.org/doi/full/10.15252/embj.2022113168, type={value=Publication, label=Publication}, thumbnail={alt_text=bitbio-ioGlutamatergic-Neurons, width=1700, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioGlutamatergic%20Neurons/bitbio-ioGlutamatergic-Neurons.jpg, height=1300}, year={value=2023, label=2023}, summary=<p>Qiaojin Lin et al</p> <p><em>The EMBO Journal</em></p> <p>2023</p> <p>Featuring opti-ox powered hiPSC-derived <a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank">glutamatergic neurons</a> with constitutive expression of Cas9</p>, date_published=1685404800000, sort_date=1685404800000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p>Qiaojin Lin et al</p> <p><em>The EMBO Journal</em></p> <p>2023</p> <p>Featuring opti-ox powered hiPSC-derived <a href="https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001" rel="noopener" target="_blank">glutamatergic neurons</a> with constitutive expression of Cas9</p>, listing_button_label=Read more}, {hs_name=Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons, hs_id=178046423390, hs_path=schizophrenia-risk-gene-znf804a-controls-ribosome-localization-and-synaptogenesis-in-developing-human-neurons-article, button_label=Read more, button_link=https://www.biorxiv.org/content/10.1101/2024.02.02.578424v1, type={value=Publication, label=Publication}, thumbnail={alt_text=bitbio-ioGlutamatergic-Neurons, width=1700, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioGlutamatergic%20Neurons/bitbio-ioGlutamatergic-Neurons.jpg, height=1300}, year={value=2024, label=2024}, summary=<p><span>Deepak P.</span><span>&nbsp;</span><span>Srivastava, et al</span></p> <p><em>bioRxiv</em></p> <p>2024</p> <p>Featuring <a href="https://www.bit.bio/platform" rel="noopener" target="_blank">opti-ox </a>enabled glutamatergic neurons iPS cell line</p>, date_published=1706832000000, sort_date=1706832000000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=<p><span>Deepak P.</span><span>&nbsp;</span><span>Srivastava, et al</span></p> <p><em>bioRxiv</em></p> <p>2024</p> <p>Featuring <a href="https://www.bit.bio/platform" rel="noopener" target="_blank">opti-ox</a><sup> </sup>enabled glutamatergic neurons iPS cell line</p>, listing_button_label=Read more}, {hs_name=Circadian clocks in human cerebral organoids, hs_id=178051600304, hs_path=circadian-clocks-in-human-cerebral-organoids-article, button_label=Read more, button_link=https://www.biorxiv.org/content/10.1101/2024.02.20.580978v1.full, type={value=Publication, label=Publication}, thumbnail={alt_text=Hero image_CRISPR-Ready ioMicroglia, width=1422, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioMicroglia/Hero%20image_CRISPR-Ready%20ioMicroglia.png, height=1920}, year={value=2024, label=2024}, summary=<p>Rzechorzek, et al</p> <p><em>bioRxiv</em></p> <p>2024</p> <p>Featuring <a href="https://www.bit.bio/platform" rel="noopener" target="_blank">opti-ox</a><sup> </sup>enabled microglia male iPS cell line and opti-ox enabled glutamatergic neurons iPS cell line</p>, date_published=1708473600000, sort_date=1708473600000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioMicroglia, label=ioMicroglia}], media_contact=<p>Rzechorzek, et al</p> <p><em>bioRxiv</em></p> <p>2024</p> <p>Featuring <a href="https://www.bit.bio/platform" rel="noopener" target="_blank">opti-ox</a><sup> </sup>enabled microglia male iPS cell line and opti-ox enabled glutamatergic neurons iPS cell line</p>, listing_button_label=Read more}, {hs_name=CRISPR and the Art of Perturbation Screening: Unbiased functional genomic screening meets the best human cellular models, hs_id=161968263475, hs_path=crispr-and-the-art-of-perturbation-screening-unbiased-functional-genomic-screening-meets-the-best-human-cellular-models, button_label=Explore ioCRISPR-Ready Cells, button_link=https://www.bit.bio/iocrispr-ready, type={value=Talk, label=Talk}, thumbnail={alt_text=, width=1318, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/BitBio2022/Resources%20listing/hubdb-thumbs/resources/CRISPR%20and%20the%20Art%20of%20Perturbation%20Screening-min.png, height=1000}, year={value=2021, label=2021}, summary=<p>Kam Dhaliwal <span>| </span>SVP Strategic Alliances | bit.bio</p> <p><br>Talk at ELRIG CRISPR in Drug Discovery</p>, date_published=1706140800000, sort_date=1636070400000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioSkeletal Myocytes, label=ioSkeletal Myocytes}, {value=ioGlutamatergic Neurons HTT 50CAG/WT, label=ioGlutamatergic Neurons HTT 50CAG/WT}, {value=ioSensory Neurons, label=ioSensory Neurons}], media_contact=null, listing_button_label=Watch now}, {hs_name=Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery, hs_id=161968263476, hs_path=consistent-and-scalable-human-ipsc-derived-cells-for-in-vitro-disease-modelling-and-drug-discovery, button_label=Explore ioCells, button_link=https://www.bit.bio/discover-iocells, type={value=Talk, label=Talk}, thumbnail={alt_text=, width=900, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/DDD_banner_square.jpeg, height=652}, year={value=2020, label=2020}, summary=<p>Kam Dhaliwal <span>|&nbsp;</span> SVP Strategic Alliances | bit.bio<br>Dr Thomas Moreau <span>|</span> Head of Research | bit.bio</p> <p><br>Talk at ELRIG Drug Discovery Digital</p>, date_published=1706400000000, sort_date=1600905600000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioSkeletal Myocytes, label=ioSkeletal Myocytes}, {value=ioGlutamatergic Neurons HTT 50CAG/WT, label=ioGlutamatergic Neurons HTT 50CAG/WT}], media_contact=null, listing_button_label=Watch now}, {hs_name=Precision Cellular Reprogramming for Scalable and Consistent Human Neurodegenerative Disease Models, hs_id=161968263479, hs_path=precision-cellular-reprogramming-for-scalable-and-consistent-human-neurodegenerative-disease-models, button_label=Explore ioDisease Model Cells, button_link=https://www.bit.bio/iodisease-models, type={value=Talk, label=Talk}, thumbnail={alt_text=, width=1860, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Resources/Tech%20Nets%20online%20symposium%20header%20(1).png, height=1260}, year={value=2023, label=2023}, summary=<p>Madeleine Garrett | Field Application Specialist | bit.bio</p>, date_published=1709078400000, sort_date=1681344000000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGlutamatergic Neurons HTT 50CAG/WT, label=ioGlutamatergic Neurons HTT 50CAG/WT}, {value=ioMicroglia, label=ioMicroglia}, {value=ioGlutamatergic Neurons TDP-43 M337V Het, label=ioGlutamatergic Neurons TDP-43 M337V Het}, {value=ioGlutamatergic Neurons TDP-43 M337V Hom, label=ioGlutamatergic Neurons TDP-43 M337V Hom}, {value=ioGlutamatergic Neurons MAPT P301S/WT, label=ioGlutamatergic Neurons MAPT P301S/WT}, {value=ioGlutamatergic Neurons MAPT P301S/P301S, label=ioGlutamatergic Neurons MAPT P301S/P301S}, {value=ioGlutamatergic Neurons MAPT N279K/WT, label=ioGlutamatergic Neurons MAPT N279K/WT}, {value=ioOligodendrocyte-like cells, label=ioOligodendrocyte-like cells}, {value=ioMotor Neurons, label=ioMotor Neurons}], media_contact=null, listing_button_label=Watch now}, {hs_name=Industrialising Cellular Reprogramming: Leveraging opti-ox Technology to Manufacture Human Cells with Unprecedented Consistency, hs_id=161968263480, hs_path=industrialising-cellular-reprogramming-leveraging-opti-ox-technology-to-manufacture-human-cells-with-unprecedented-consistency, button_label=null, button_link=null, type={value=Talk, label=Talk}, thumbnail={alt_text=, width=1024, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Resources/Resources/video/Squarespace+Thumbnail+Template+-+AM23-01-01-01.png, height=768}, year={value=2023, label=2023}, summary=<p>Innovation showcase talk at ISSCR</p> <p>Marius Wernig MD, PhD | Stanford&nbsp;</p> <p>Mark Kotter, MD, PhD | bit.bio</p>, date_published=1709683200000, sort_date=1688083200000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGABAergic Neurons, label=ioGABAergic Neurons}, {value=ioSensory Neurons, label=ioSensory Neurons}, {value=CRISPR-Ready ioCells, label=CRISPR-Ready ioCells}], media_contact=<p>V1<br><br>2023<br><br>ISSCR 2023</p>, listing_button_label=Watch now}, {hs_name=Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons, hs_id=161968263497, hs_path=in-conversation-with-charles-river-video-part-2, button_label=null, button_link=null, type={value=Video, label=Video}, thumbnail={alt_text=, width=687, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/CRL%20video%20posts/crl%202%20webpage%20image-2.png, height=476}, year={value=2021, label=2021}, summary=<p>Dr Marijn Vlaming | Head of Biology, et al.</p> <p>Charles River &amp; bit.bio</p>, date_published=1705017600000, sort_date=1637107200000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGlutamatergic Neurons TDP-43 M337V Het, label=ioGlutamatergic Neurons TDP-43 M337V Het}, {value=ioGlutamatergic Neurons TDP-43 M337V Hom, label=ioGlutamatergic Neurons TDP-43 M337V Hom}], media_contact=null, listing_button_label=Watch }, {hs_name=In Conversation with Charles River, hs_id=161968263498, hs_path=in-conversation-with-charles-river-video, button_label=Discover our ioCells portfolio, button_link=/discover-iocells, type={value=Video, label=Video}, thumbnail={alt_text=, width=834, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/CRL%20video%20posts/CRL%20video%20%231%20card%20for%20webpage%20(thinner%20gradient%20line)-1.png, height=590}, year={value=2021, label=2021}, summary=<p>Dr Marijn Vlaming <span>|</span> Head of Biology<br>Charles River</p>, date_published=1705363200000, sort_date=1636675200000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}], media_contact=null, listing_button_label=Watch}, {hs_name=Modelling neurodevelopment | Investigating the impact of maternal immune activation on neurodevelopment using human iPSC-derived cells, hs_id=161968263519, hs_path=modelling-neurodevelopment-webinar-2022, button_label=Explore ioGlutamatergic Neurons, button_link=https://www.bit.bio/products/nerve-cells/glutamatergic-neurons-wild-type-io1001, type={value=Webinar, label=Webinar}, thumbnail={alt_text=, width=1200, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/BitBio2022/product-page/Colour%20webinar%20with%2060x%20Map2-com.jpg, height=732}, year={value=2022, label=2022}, summary=<p><span>Dr Deepak Srivastava | King’s College London<br><br></span><span></span></p>, date_published=1707436800000, sort_date=1649376000000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGABAergic Neurons, label=ioGABAergic Neurons}], media_contact=null, listing_button_label=Watch now}, {hs_name=Rethinking Developmental Biology With Cellular Reprogramming, hs_id=161968263524, hs_path=rethinking-developmental-biology-with-cellular-reprogramming, button_label=Explore ioCells, button_link=https://www.bit.bio/discover-iocells, type={value=Webinar, label=Webinar}, thumbnail={alt_text=, width=1860, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Upcoming%20Webinars/Tech%20Nets%202023/bit.bio_ioGlutamatergic%20Neurons_20xMAP2(red)Hoescht(blue)_day12v2.png, height=1260}, year={value=2023, label=2023}, summary=<p>Mark Kotter | CEO and founder | bit.bio</p> <p>Marius Wernig | Professor Departments of Pathology and Chemical and Systems Biology |&nbsp; Stanford University</p>, date_published=1709164800000, sort_date=1681776000000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGABAergic Neurons, label=ioGABAergic Neurons}, {value=ioMicroglia, label=ioMicroglia}, {value=Cell therapy, label=Cell therapy}, {value=ioSensory Neurons, label=ioSensory Neurons}, {value=ioOligodendrocyte-like cells, label=ioOligodendrocyte-like cells}], media_contact=null, listing_button_label=Watch now}, {hs_name=Addressing the Reproducibility Crisis | Driving Genome-Wide Consistency in Cellular Reprogramming, hs_id=161968263525, hs_path=addressing-the-reproducibility-crisis-driving-genome-wide-consistency-in-cellular-reprogramming, button_label=Explore ioCells, button_link=https://www.bit.bio/discover-iocells, type={value=Webinar, label=Webinar}, thumbnail={alt_text=, width=1860, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Upcoming%20Webinars/Tech%20Nets%2019th%20July%202023/bit.bio_ioGlutamatergic%20Neurons_60xMAP2(red)Hoescht(blue)TUBB3(blue)_day4.jpg, height=1260}, year={value=2023, label=2023}, summary=<p>Dr Ania Wilczynska | Head of Computational Genomics | Non-Clinical | bit.bio</p>, date_published=1709769600000, sort_date=1689724800000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioGABAergic Neurons, label=ioGABAergic Neurons}, {value=ioSensory Neurons, label=ioSensory Neurons}, {value=CRISPR-Ready ioGlutamatergic Neurons, label=CRISPR-Ready ioGlutamatergic Neurons}], media_contact=null, listing_button_label=Watch now}, {hs_name=Running Large-Scale CRISPR Screens in Human Neurons, hs_id=161968263528, hs_path=running-large-scale-crispr-screens-in-human-neurons, button_label=null, button_link=null, type={value=Webinar, label=Webinar}, thumbnail={alt_text=, width=1200, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Emails/Header%20images/Header%20Images%20-%20ICC%20only/Running%20Large-Scale%20CRISPR%20Screens%20in%20Human%20Neurons_email%20header.png, height=678}, year={value=2023, label=2023}, summary=<p>Emmanouil Metzakopian | Vice President, Research and Development | bit.bio</p> <p>Javier Conde-Vancells | Director Product Management | bit.bio</p>, date_published=1710460800000, sort_date=1700524800000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=CRISPR-Ready ioCells, label=CRISPR-Ready ioCells}, {value=CRISPR-Ready ioGlutamatergic Neurons, label=CRISPR-Ready ioGlutamatergic Neurons}, {value=CRISPR-Ready ioMicroglia, label=CRISPR-Ready ioMicroglia}], media_contact=null, listing_button_label=Watch now}, {hs_name=Human iPSC-Based Models of Glial Cells for Studying Neurodegenerative Disease, hs_id=183096620633, hs_path=human-ipsc-based-models-of-glial-cells-for-studying-neurodegenerative-disease, button_label=null, button_link=null, type={value=Webinar, label=Webinar}, thumbnail={alt_text=bitbio-oligodendrocyte-like-cells-O4-MBP-immunocytochemistry, width=1000, url=https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Website%20content/Product%20pages/ioOligodendrocyte-like%20cells/bitbio-oligodendrocyte-like-cells-O4-MBP-immunocytochemistry.jpg, height=1350}, year={value=2024, label=2024}, summary=Valentina Fossati, PhD | Senior Research Investigator | The New York Stem Cell Foundation<br><br>Inês Ferreira | Senior Product Manager | bit.bio, date_published=1732233600000, sort_date=1732233600000, tags=[{value=ioGlutamatergic Neurons, label=ioGlutamatergic Neurons}, {value=ioOligodendrocyte-like cells, label=ioOligodendrocyte-like cells}], media_contact=null, listing_button_label=Watch now}])
Human iPSC-Based Models of Glial Cells for Studying Neurodegenerative Disease Webinar
Human iPSC-Based Models of Glial Cells for Studying Neurodegenerative Disease
Valentina Fossati, PhD | Senior Research Investigator | The New York Stem Cell Foundation

Inês Ferreira | Senior Product Manager | bit.bio
Watch now
Circadian clocks in human cerebral organoids Publication
Circadian clocks in human cerebral organoids

Rzechorzek, et al

bioRxiv

2024

Featuring opti-ox enabled microglia male iPS cell line and opti-ox enabled glutamatergic neurons iPS cell line

Read more
Generation and characterisation of a panel of human iPSC-derived neurons and microglia carrying early and late onset relevant mutations for Alzheimer’s disease Poster
Generation and characterisation of a panel of human iPSC-derived neurons and microglia carrying early and late onset relevant mutations for Alzheimer’s disease
Smith, et al. 
bit.bio
2024
Download
Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons Publication
Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons

Deepak P. Srivastava, et al

bioRxiv

2024

Featuring opti-ox enabled glutamatergic neurons iPS cell line

Read more
Running Large-Scale CRISPR Screens in Human Neurons Webinar
Running Large-Scale CRISPR Screens in Human Neurons

Emmanouil Metzakopian | Vice President, Research and Development | bit.bio

Javier Conde-Vancells | Director Product Management | bit.bio

Watch now
Rewiring of the promoter-enhancer interactome and regulatory landscape in glioblastoma orchestrates gene expression underlying neurogliomal synaptic communication Publication
Rewiring of the promoter-enhancer interactome and regulatory landscape in glioblastoma orchestrates gene expression underlying neurogliomal synaptic communication

Chakraborty et al
Nature Communications
2023

Featuring ioGlutamatergic Neurons

Read more
Addressing the Reproducibility Crisis | Driving Genome-Wide Consistency in Cellular Reprogramming Webinar
Addressing the Reproducibility Crisis | Driving Genome-Wide Consistency in Cellular Reprogramming

Dr Ania Wilczynska | Head of Computational Genomics | Non-Clinical | bit.bio

Watch now
Industrialising Cellular Reprogramming: Leveraging opti-ox Technology to Manufacture Human Cells with Unprecedented Consistency Talk
Industrialising Cellular Reprogramming: Leveraging opti-ox Technology to Manufacture Human Cells with Unprecedented Consistency

Innovation showcase talk at ISSCR

Marius Wernig MD, PhD | Stanford 

Mark Kotter, MD, PhD | bit.bio

Watch now
Modelling neurodegeneration: Human isogenic system to study FTD & ALS Poster
Modelling neurodegeneration: Human isogenic system to study FTD & ALS

Oosterveen, et al

bit.bio & Charles River Laboratories

2023

View
HNRNPH1 regulates the neuroprotective cold‐shock protein RBM3 expression through poison exon exclusion Publication
HNRNPH1 regulates the neuroprotective cold‐shock protein RBM3 expression through poison exon exclusion

Qiaojin Lin et al

The EMBO Journal

2023

Featuring opti-ox powered hiPSC-derived glutamatergic neurons with constitutive expression of Cas9

Read more
Rethinking Developmental Biology With Cellular Reprogramming Webinar
Rethinking Developmental Biology With Cellular Reprogramming

Mark Kotter | CEO and founder | bit.bio

Marius Wernig | Professor Departments of Pathology and Chemical and Systems Biology |  Stanford University

Watch now
Precision Cellular Reprogramming for Scalable and Consistent Human Neurodegenerative Disease Models Talk
Precision Cellular Reprogramming for Scalable and Consistent Human Neurodegenerative Disease Models

Madeleine Garrett | Field Application Specialist | bit.bio

Watch now
Development and characterisation of a robust in vitro disease model to study tauopathies Poster
Development and characterisation of a robust in vitro disease model to study tauopathies

Ritsma, et al

Charles River Laboratories & bit.bio

2022

View
Rapid and consistent generation of functional microglia from reprogrammed hiPSCs to study neurodegeneration and neuroinflammation Poster
Rapid and consistent generation of functional microglia from reprogrammed hiPSCs to study neurodegeneration and neuroinflammation

Raman, et al

bit.bio

2022

View
Interferon-γ exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression Publication
Interferon-γ exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression

Pavinlek, et al

Frontiers in Psychiatry

2022

Using ioGlutamatergic Neurons

 

 

Read more
Glutamatergic Neurons and Brain Cyst Formation Publication
Glutamatergic Neurons and Brain Cyst Formation

Bando, et al

Frontiers in Cellular and Infection Microbiology

2022

Using ioGlutamatergic Neurons

 

 

Read more
Compounds co-targeting kinases in axon regulatory pathways promote regeneration and behavioral recovery after spinal cord injury in mice Publication
Compounds co-targeting kinases in axon regulatory pathways promote regeneration and behavioral recovery after spinal cord injury in mice

Mah, et al

Experimental Neurology

2022

Using ioGlutamatergic Neurons

Read more
Modelling neurodevelopment | Investigating the impact of maternal immune activation on neurodevelopment using human iPSC-derived cells Webinar
Modelling neurodevelopment | Investigating the impact of maternal immune activation on neurodevelopment using human iPSC-derived cells

Dr Deepak Srivastava | King’s College London

Watch now
Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons Video
Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons

Dr Marijn Vlaming | Head of Biology, et al.

Charles River & bit.bio

Watch
In Conversation with Charles River Video
In Conversation with Charles River

Dr Marijn Vlaming | Head of Biology
Charles River

Watch
CRISPR and the Art of Perturbation Screening: Unbiased functional genomic screening meets the best human cellular models Talk
CRISPR and the Art of Perturbation Screening: Unbiased functional genomic screening meets the best human cellular models

Kam Dhaliwal | SVP Strategic Alliances | bit.bio


Talk at ELRIG CRISPR in Drug Discovery

Watch now
High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery Poster
High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery

Lachize, et al

Courtesy of Charles River Laboratories

2020

View
Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery Talk
Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

Kam Dhaliwal SVP Strategic Alliances | bit.bio
Dr Thomas Moreau | Head of Research | bit.bio


Talk at ELRIG Drug Discovery Digital

Watch now
Lipid-Bilayer-Supported 3D Printing of Human Cerebral Cortex Cells Reveals Developmental Interactions Publication
Lipid-Bilayer-Supported 3D Printing of Human Cerebral Cortex Cells Reveals Developmental Interactions

Zhou L, et al 

Advanced Science News

2020

Using ioGlutamatergic Neurons

Read more
Reprogramming the stem cell for a new generation of cures Publication
Reprogramming the stem cell for a new generation of cures

Davenport A, Frolov T & Kotter M

Drug Discovery World

2020

 

 

Read more
Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes Publication
Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes

Pawlowski M et al
Stem Cell Reports

2017

Read more

Related pages

Our platform Discover the cell coding platform behind our cells
Product catalogue See the range of human iPSC-derived cells for research and drug discovery
Resources Explore our latest scientific insights, webinars, blogs and videos